Biodesix (BDSX) Gross Margin: 2019-2025
Historic Gross Margin for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to 81.14%.
- Biodesix's Gross Margin rose 416.00% to 81.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 79.82%, marking a year-over-year increase of 209.00%. This contributed to the annual value of 78.17% for FY2024, which is 467.00% up from last year.
- Per Biodesix's latest filing, its Gross Margin stood at 81.14% for Q3 2025, which was up 1.60% from 79.86% recorded in Q2 2025.
- In the past 5 years, Biodesix's Gross Margin registered a high of 81.14% during Q3 2025, and its lowest value of 36.89% during Q1 2021.
- Over the past 3 years, Biodesix's median Gross Margin value was 78.37% (recorded in 2024), while the average stood at 76.71%.
- In the last 5 years, Biodesix's Gross Margin slumped by 3,209bps in 2021 and then soared by 2,327bps in 2022.
- Over the past 5 years, Biodesix's Gross Margin (Quarterly) stood at 65.49% in 2021, then grew by 10bps to 65.59% in 2022, then spiked by 1,141bps to 77.00% in 2023, then spiked by 175bps to 78.75% in 2024, then spiked by 416bps to 81.14% in 2025.
- Its Gross Margin was 81.14% in Q3 2025, compared to 79.86% in Q2 2025 and 79.38% in Q1 2025.